Dow Jones

40,762.36

1.37%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

CGEN

Compugen (CGEN)

Compugen Ltd

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CGEN

<< Anterior 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
27/07/2015	06:00	Business Wire	Compugen Second Quarter 2015 Conference Call Scheduled for Tuesday, August 4, 2015 at 10:00 AM ET	NASDAQ:CGEN	Compugen Ltd
16/06/2015	10:16	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CGEN	Compugen Ltd
15/06/2015	06:00	Business Wire	Compugen to Present at JMP Securities Life Sciences Conference in New York	NASDAQ:CGEN	Compugen Ltd
11/06/2015	08:09	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:CGEN	Compugen Ltd
08/06/2015	06:07	Business Wire	Compugen to Disclose Novel Cancer Immunotherapy Target Candidate & Comprehensive Target Characterization Infrastructure at To...	NASDAQ:CGEN	Compugen Ltd
28/05/2015	06:00	Business Wire	Compugen to Present at Jefferies 2015 Global Healthcare Conference in New York	NASDAQ:CGEN	Compugen Ltd
27/05/2015	06:00	Business Wire	Compugen to Hold Analyst and Investor Day in New York	NASDAQ:CGEN	Compugen Ltd
05/05/2015	06:40	Business Wire	Compugen Ltd. Reports First Quarter 2015 Results	NASDAQ:CGEN	Compugen Ltd
28/04/2015	06:00	Business Wire	Compugen First Quarter 2015 Conference Call Scheduled for Tuesday, May 5, 2015 at 10:00 AM ET	NASDAQ:CGEN	Compugen Ltd
23/04/2015	03:51	Analyst Ratings Network	Compugen Research Coverage Started at Jefferies Group (CGEN)	NASDAQ:CGEN	Compugen Ltd
14/04/2015	06:02	Business Wire	Compugen Obtains Rights to Use Biological Systems and Materials from the US National Institutes of Health	NASDAQ:CGEN	Compugen Ltd
06/04/2015	06:10	Business Wire	Compugen to Present at Two Immuno-Oncology Conferences in April	NASDAQ:CGEN	Compugen Ltd
19/03/2015	06:09	Business Wire	Compugen Announces Planned Relocation of Headquarters to Larger Facilities	NASDAQ:CGEN	Compugen Ltd
12/03/2015	11:09	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:CGEN	Compugen Ltd
02/03/2015	06:09	Business Wire	Compugen to Present at Two Oncology Conferences in March	NASDAQ:CGEN	Compugen Ltd
27/02/2015	15:08	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CGEN	Compugen Ltd
23/02/2015	06:04	Business Wire	Compugen Expands and Strengthens Business Development Team	NASDAQ:CGEN	Compugen Ltd
10/02/2015	06:10	Business Wire	Compugen Ltd. Reports Fourth Quarter and Calendar 2014 Results	NASDAQ:CGEN	Compugen Ltd
09/02/2015	06:14	Business Wire	Compugen Presents New Results Supporting CGEN-15049 as Potential Cancer Immunotherapy Target	NASDAQ:CGEN	Compugen Ltd
03/02/2015	06:09	Business Wire	Compugen Fourth Quarter and Year-End 2014 Conference Call Scheduled for Tuesday, February 10, 2015 at 10:00 AM EST	NASDAQ:CGEN	Compugen Ltd
02/02/2015	06:39	Business Wire	Compugen to Present Cancer Immunotherapy Targets at Two Tumor Immunology Conferences This Month	NASDAQ:CGEN	Compugen Ltd
05/01/2015	06:14	Business Wire	Compugen Discloses Initial Experimental Results for Predicted Antibody Drug Conjugate Targets	NASDAQ:CGEN	Compugen Ltd
18/12/2014	06:02	Business Wire	Compugen Enters Immuno-Oncology Research Collaboration with Johns Hopkins University	NASDAQ:CGEN	Compugen Ltd
03/12/2014	06:01	Business Wire	Compugen to Present at Oppenheimer 25th Annual Healthcare Conference	NASDAQ:CGEN	Compugen Ltd
02/12/2014	06:07	Business Wire	Compugen Announces Experimental Confirmation of Additional Methodology for Discovery of Cancer-Related Immune Checkpoints	NASDAQ:CGEN	Compugen Ltd
12/11/2014	06:01	Business Wire	Compugen to Present at Jefferies 2014 Global Healthcare Conference in London	NASDAQ:CGEN	Compugen Ltd
29/10/2014	06:13	Business Wire	Compugen Ltd. Reports Third Quarter 2014 Financial Results	NASDAQ:CGEN	Compugen Ltd
27/10/2014	06:01	Business Wire	Compugen Discloses Successful Validation Results for Novel B7/CD28–like Cancer Immunotherapy Target Candidate	NASDAQ:CGEN	Compugen Ltd
22/10/2014	06:11	Business Wire	Compugen Third Quarter 2014 Conference Call Scheduled for Wednesday, October 29, 2014 at 10:00 AM ET	NASDAQ:CGEN	Compugen Ltd
14/10/2014	13:02	Business Wire	Compugen Achieves Second Preclinical Milestone in Cancer Immunotherapy Collaboration with Bayer	NASDAQ:CGEN	Compugen Ltd